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Abstract
Background: CD8 T cells assist in the clearance of respiratory syncytial virus (RSV) infection from the lungs. However, disease
after RSV infection is in part caused by excessive T cell activity, and a balance is therefore needed between beneficial and
harmful cellular immune responses. The chemokine CCL3 (MIP1a) is produced following RSV infection and is broadly
chemotactic for both T cells and natural killer (NK) cells. We therefore investigated its role in RSV disease.
Methodology/Principal Findings: CCL3 was produced biphasically, in both the early (day 1) and late (day 6–7) stages of
infection. CCL3 depletion did not alter the recruitment of natural killer (NK) cells to the lungs during the early stage, but
depletion did affect the later adaptive phase. While fewer T cells were recruited to the lungs of either CCL3 knockout or anti-
CCL3 treated RSV infected mice, more RSV-specific pro-inflammatory T cells were recruited to the lung when CCL3
responses were impaired. This increase in RSV-specific pro-inflammatory T cells was accompanied by increased weight loss
and illness after RSV infection.
Conclusions/Significance: CCL3 regulates the balance of T cell populations in the lung and can alter the outcome of RSV
infection. Understanding the role of inflammatory mediators in the recruitment of pathogenic T cells to the lungs may lead
to novel methods to control RSV disease.
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Introduction
Respiratory Syncytial Virus (RSV) is the leading cause of infant
hospitalization [1,2]. Currently, there is no vaccine against RSV and
the only specific intervention for RSV is a virus-specific monoclonal
antibody. The bronchiolitis and airway occlusion that can result from
RSV infection are believed to be immunopathological in nature,
because large numbers of inflammatory cells are recruited to and
activated in the lungs [3,4]. The contribution of the immune system
to the bronchiolitis seen during RSV infection opens up possible
therapeutic options based on dampening the pathogenic immune
response. T cells have been demonstrated to be an important part of
this pathogenic inflammatory infiltrate [5]; therefore, inflammatory
mediators which recruit T cells to the lung are candidates for novel
therapeutics. However, T cells recruited following RSV infection can
be either pro-inflammatory [6] or regulatory [7,8] with the
consequence that interventions that lead to reduced recruitment of
regulatory T cells may increase inflammation.
One potential target for intervention is CCL3 (MIP1a), chemo-
tactic for both T cells and natural killer (NK) cells. In vitro, CCL3 is
produced following RSV infection of airway epithelial cells [9].
CCL3 mRNA and protein are both detected in bronchoalveolar
lavage (BAL) samples of infants infected with RSV [10], and CCL3
protein levels correlate with the severity of hypoxia in bronchiolitis
[11]. We have previously shown that CCL3 is significantly
upregulated both during primary murine RSV infection [12,13]
and in enhanced immunopathology after antigenic sensitization [14].
In the current study we observed a biphasic release of CCL3
during primary RSV infection. The early production is from
macrophages and the later phase from CD8 T cells. Depletion of
CCL3 (by antibody or CCL3 knockout) during RSV infection
reduced T cell recruitment, did not affect NK cell responses but
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9381increased recruitment of RSV-specific CD8 cells making TNF and
IFNc, thereby increasing disease severity.
Results
The Production of CCL3 Following RSV Infection Is
Biphasic
As observed previously [13], RSV infection led to significant
weight loss on days 6 and 7 post infection (p.i.; Figure 1a), when
pulmonary cell recruitment also peaked (Figure 1b). However,
CCL3RNAinlungtissueshowedadoublepeakondays1and7p.i.
(Figure 1c). CCL3 protein concentration was measured in the sera,
nasal wash, BAL and lung homogenate supernatant. None was
detected in sera or nasal wash, but in the BAL there was a peak of
CCL3 at day 0 and a second peak on day 7 (not depicted). In lung
homogenate there were also two peaks of CCL3 production on days
1 and 7 p.i. (Figure 1d). Using intracellular staining to detect CCL3
in CD3
+ T cells, following RSV peptide stimulation, a peak of
CCL3 production was seen on day 7 p.i. (Figure 1e).
CCL3 Does Not Contribute to Innate Effector Cell
Recruitment Following RSV Infection
In previous studies we described an early peak of inflammatory
mediator production from alveolar macrophages, which was
important in the recruitment of NK cells [13]. To determine the
contributionof CCL3 to NKcell recruitment, we used a chemotaxis
assay. NK cells were enriched using negative magnetic cell sorting
from spleen lymphocytes prepared by Ficoll-Paque separation. The
enriched cells were added to chemotaxis assay plates to which the
potentially chemotactic medium had been added. After incubation,
cell migration was quantified by flow cytometry. We found that NK
cells were recruited by CCL3 (Figure 2a) and CCL2 (data not
depicted). There was no increase in NK cell detection when cells
were pre-mixed with CCL3, indicating an increase in chemotaxis
rather than chemokinesis (data not depicted).
We saw no chemotaxis towards bronchoalveolar lavage (BAL)
collected from RSV infected mice at 24 hours post RSV infection
(data not depicted). However the levels of CCL3 measured in the
BAL were at 4 pg/ml and the lowest level we used in the
chemotaxis assay was 62.5 ng/ml. As BAL supernatant provided
too low a concentration of chemokines for NK cell chemotaxis,
we used the supernatant from enriched alveolar macrophages
that had been exposed to RSV. This supernatant caused
chemotaxis equivalent to that of 200 ng/ml CCL3 and
significantly greater than chemotaxis caused by supernatant from
control alveolar macrophages (p,0.001, Figure 2a). The
supernatant from alveolar macrophages incubated with UV
inactivated RSV had no effect on chemotaxis. Treatment of
supernatant with either anti-CCL3 or anti-TNF did not
significantly affect NK chemotaxis.
The same effect was observed using in vivo studies. Treatment of
mice with anti-CCL3 prior to RSV infection did not significantly
alter cell recruitment on day 4 post infection (Figure 2b) nor the
percentage of NK cells recruited (Figure 2c). No difference was seen
in the peak viral load by plaque assay on day 4 following anti-CCL3
treatment (Figure 2d) or in CCL3
2/2 knockout mice compared to
wild type (data not depicted), this was confirmed by RSV specific
qPCR estimation of viral RNA levels in lung homogenate.
CCL3 Is Important in the Recruitment of T Cells to the
Lung
C57BL/6 mice genetically deficient in CCL3 (CCL3
2/2), were
used to analyze the response to RSV in the absence of CCL3.
There was no detectable CCL3 mRNA in CCL3
2/2 mice (data
not depicted). During primary infection CCL3
2/2 mice showed
significantly reduced cell recruitment to the lung (p,0.05,
Figure 3a) compared to wildtype C57BL/6 mice on day 7. The
recruitment of CD4 and CD8 T cells in the lung was significantly
reduced in CCL3
2/2 mice (p,0.01, Figure 3b). There was no
difference in the number of RSV specific IFNc secreting cells
measured by ELISPOT (Figure 3c).
Since BALB/c mice respond to RSV infection with more
pronounced pathology than C57BL/6 and have well character-
ized CD8 epitopes, we used CCL3 depletion by antibody in this
strain to assess the role of CCL3 in RSV infected BALB/c mice.
Mice treated with anti-CCL3 on day 21 and +1 of RSV infection
showed reduced cellular recruitment to the lungs on day 7 p.i.
(p,0.01, Figure 4a), due to reduced numbers of both CD4
(p,0.05) and CD8 T cells (Figure 4b). As in CCL3
2/2 mice, there
was no change in the proportion of RSV specific T cells as shown
by detection of RSV M2 peptide (M282290) specific cells
(Figure 4c). However, the total number of M2 specific CD8 cells
in the lungs was reduced in anti-CCL3 treated mice (Figure 4d)
reflecting reduced cell numbers.
RSV-infected mice treated with anti-CCL3 lost significantly
more weight than control mice on days 6 and 7 p.i. (p,0.001,
Figure 5a). RSV specific production of cytokines by CD8 T cells
was measured following stimulation with the immunodominant
RSV M2 peptide. At the peak of weight loss (day 7) there was a
significantly greater proportion (p,0.05, Figure 5b) and number
(Figure 5c) of RSV specific TNF producing CD8 T cells after
CCL3 depletion. There was also an increased percentage
(Figure 5d) and total number (Figure 5e) of RSV specific IFNc
producing CD8 cells.
TNF Production Contributes to RSV Pathology
Since TNF producing CD8 cells increased in parallel with the
increased weight loss, we looked at whether TNF depletion
inhibited RSV pathology. Mice treated with anti-TNF lost
significantly less weight than control mice at the peak of disease
(p,0.01, Figure 6a). There was also significantly reduced total cell
recruitment to the airways (p,0.05, Figure 6b). CD4 and CD8 T
cell recruitment to the airways was also significantly reduced
(p,0.001, Figure 6c). Anti-TNF treatment reduced the number of
RSV specific CD8 T cells recruited to the lungs (p,0.05,
Figure 6d) and increased viral load – measured by plaque assay
(p,0.05, Figure 6e).
Discussion
Here we demonstrate that CCL3 was produced biphasically
during RSV infection. It is known that other chemokines are also
produced in a biphasic manner [12,14] and that the early peak of
chemokine is principally macrophage derived [13]. The early
wave of mediator release causes innate effector cell recruitment
particularly neutrophils and NK cells. However, both in vitro and in
vivo we saw no contribution of CCL3 to the recruitment of NK
cells suggesting that other mediators produced by macrophages
were responsible for this cellular influx and that viral clearance still
occurs. The second peak of chemokine production was T cell
associated; when T cells were depleted during primary RSV
infection, mediator levels were also reduced [6]. This second T cell
derived wave of chemokine production may potentiate the
recruitment of further T cells, and contributing to the disease
seen following RSV infection. As has previously been observed in
RSV infected CCL3
2/2 mice [15], CCL3 depletion reduced T
cell recruitment.
CCL39s Effect on RSV Infection
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increased weight loss. This is of interest because cellular burden in
the lungs is often taken as an indicator of severity of inflammation
and of disease. In this case, disease was increased despite reduced
cell recruitment. The cause of this increased disease is likely to be
increased inflammatory mediator production. Our finding that
CCL3 inhibition enhances pathology is similar to the finding that
in a model of nephritis CCR1
2/2 (the main receptor for CCL3)
mice have enhanced pathology associated with increased TNF
levels [16]. In the current study we observed that CCL3 depletion
increased the number of RSV-specific TNF producing CD8 T
cells, which may be pathogenic [17,18]. In support of this
explanation, we found that TNF depletion decreased weight loss.
The critical role of CD8 T cells in RSV pathology has
previously been demonstrated. When CD8 cells are depleted,
weight loss decreases [5,6]; when virus-specific CD8 cells are
adoptively transferred into RSV infected mice, weight loss
increases [19]. These data support the idea that disease following
Figure 1. CCL3 is produced biphasically following RSV infection. Mice were infected intranasally (i.n.) with 5610
5 PFU RSV. Weight change
after RSV infection (A). Time course of cell recruitment (B), CCL3 RNA (C) protein (D) in the lung and RSV M2 (82-90) peptide stimulated CD3 T cells
stained for intracellular CCL3 (E). Points represent mean of n$4 mice 6 SEM, p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0009381.g001
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that the increase in pathology following CCL3 inhibition is caused
by an increase in the proportion of these pro-inflammatory cells.
Depletion of CD8 cells during CCL3 depletion is required to test
this conclusion. However, it is notable that there was a difference
between TNF and CCL3 depletion on peak viral load: TNF
depletion increased viral load, while CCL3 depletion had no
effect. Since neither CCL3 nor TNF increased NK cell
recruitment, this effect on viral load may be mediated by
activation of macrophages by TNF – supported by our previous
data where macrophage depletion increased peak viral load [13],
alternatively TNF has recently been demonstrated to have anti-
viral activity against RSV via the induction of b-defensin 2 [20].
How CCL3 depletion leads to increases in the number of pro-
inflammatory CD8 cells is unclear. One possibility is a change in
the number of regulatory T cells, but there was no difference in the
level of FoxP3 mRNA suggesting that this was not the case (data
not shown). It is becoming increasingly apparent that the cytokine
production profile of T cells has a critical effect on outcome.
Recently CD8 effector cells that are able to produce IL-10 and
thereby limit pathology have been described [8]. It has been
shown that CCL3 is important in the recruitment of naı ¨ve CD8
cells to the site of CD4 T cell-DC interaction [21]. CCL3 may be
important in the differential recruitment of regulatory cells
compared to the pro-inflammatory TNF producing CD8 T cells.
We conclude that CCL3 production has critically important
effects in RSV disease. Its inhibition enhances the recruitment of
pro-inflammatory T cells during later stages of infection, so
enhancing disease. The cells recruited by CCL3 are able to reduce
the pathogenic immune response. Therefore CCL3 alters the
quality and not just the magnitude of the inflammatory response in
RSV infection.
Materials and Methods
Mice and Virus
Female C57BL/6 and BALB/c mice were obtained from
Harlan Olac Ltd (Gwenapp, UK). CCL3
2/2 mice (Scya3) were
Figure 2. CCL3 is not involved in the recruitment of NK cells during RSV infection. Chemotaxis of enriched NK cells to recombinant CCL3
or supernatant (supe) from RSV, UV-RSV, or control exposed macrophages; anti-CCL3, anti-TNF or control antibody was used to assess the
chemotactic effect of specific mediators (A). BALB/c mice were treated on day 21 and +1 of RSV infection with anti-CCL3 (white bars) or control Ig
(black bars). Lung cell number (B), percentage lung NK cells (C) and lung viral load (D) on day 4 post infection. Bars represent n$3 6 SEM, ** p,0.01.
doi:10.1371/journal.pone.0009381.g002
Figure 3. CCL3
2/2 knockout mice have reduced total cellular recruitment without altering RSV specific cell number. CCL3
2/2 (white
bars) or wild type C57BL/6 control (black bars) mice were infected i.n. with RSV. Lung cell number (A) and percentage of lung CD4 and CD8 + cells on
day 7 p.i. (B). RSV specific IFNc secretion measured by lung cell ELISPOT at day 7 p.i. (C). Points represent n$4 mice 6 SEM, * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0009381.g003
CCL39s Effect on RSV Infection
PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9381obtained from B&K Universal (UK). All mice were bred in specific
pathogen free conditions and used when 6 to 10 weeks old. RSV
(A2 strain) was grown in HEp-2 cells. All work was performed
according to institutional and Home Office guidelines. Isoflurane
anaesthetized mice were infected intranasally (i.n.) with 5610
5
PFU RSV. For CCL3 depletion, mice were treated with 500 ml
polyclonal rabbit anti-CCL3 i.p. on days 21 and +1 of challenge.
For TNF depletion, mice were treated with 500 ml monoclonal rat
anti-TNF i.p. (IgG1; clone XT22 from Schering-Plough, purified
by AbD Serotec) on day 0, 2, 4 and 6 of challenge.
Cell and Tissue Recovery
After infection, animals were sacrificed by i.p. pentobarbitone
injection and tissues collected as described [22]. Bronchoalveolar
lavage (BAL) was obtained by inflating the lungs via the trachea
with 2% lidocaine in EMEM. Lungs were processed to single cell
suspension and live cells counted by trypan blue exclusion.
Cytospin slides were prepared from BAL and stained with H&E.
Detection of Cytokines and Chemokines by ELISA
Cytokine levels were assessed in BAL or lung mash supernatants
by ELISA using pairs of capture and biotinylated detection
antibodies (Cytokine: BD or Chemokine: R&D systems) following
manufacturers’ instructions. Concentrations were quantified by
comparison to recombinant cytokine standards.
Flow Cytometry of Mouse Lung Cells
Cell staining was performed as described previously [22]. Cells
were Fc blocked using anti-CD16/32. For surface staining
antibodies against surface markers (BD) or the RSV M2 MHC
class I pentamer (SYIGSINNI; Proimmune) were used. For
intracellular staining, cells were stimulated for 4 h at 37uCi n
the presence of 10 mg/ml Brefeldin A with 1 mg/ml M282-90
peptide (SYIGSINNI) plus 50 U/ml IL-2. Cells were permeabi-
lised with 0.5% saponin and stained with directly conjugated anti-
TNF, anti-IFNc or anti-CCL3-biotin and streptavidin:PE-Cy5 or
isotype control. Samples were run on an LSR (BD) and analyzed
using Winlist (Verity).
NK Cell Chemotaxis Assay
Spleen lymphocytes were isolated using Ficoll-plaque separa-
tion. NK cell enrichment from the spleen lymphocyte preparations
was performed using the MACS manual negative NK selection kit
Figure 4. CCL3 depletion reduces cell recruitment without changing RSV specific cell number. BALB/c mice were treated on day 21 and
+1 of RSV infection with anti-CCL3 (white bars) or control Ig (black bars). Lung cell numbers (A) and percentage of lung CD4 and CD8+ T cells on day 7
p.i. (B). Proportion (C) and total number (D) of RSV specific T cells in lung measured using RSV (M2) specific pentamer. Points represent n$4 mice 6
SEM, * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0009381.g004
Figure 5. CCL3 depletion increases pathology following RSV
infection. BALB/c mice were treated on day 21 and +1 of RSV
infection with anti-CCL3 (white bars/squares) or control Ig (black bars/
triangles). Weight change after RSV infection (A). Lung cells were
stimulated with the RSV M2 (82-90) peptide to determine RSV specific
responses on day 7 p.i.; percentage (B) and total (C) TNF producing CD8
cells, percentage (D) and total (E) IFNc producing CD8 cells. Points
represent n$4 mice 6 SEM, * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0009381.g005
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cells were assessed in triplicate using ChemoTx system micro-
chemotaxis 96 well plates (5 mm pore size, Neuro Probe Inc, USA).
Wells were blocked with RPMI/0.1% BSA at 37uC. The
chemotactic agent to be tested was carefully added to the wells
and the filter placed on top. Enriched NK suspension was added
onto the filter at a concentration of between 5610
6 cells/ml and
1610
7 cells/ml. Chemotaxis was measured after 1.5 hours
incubation at 37uC. Cells were collected and stained with DRAQ5
live/dead marker solution. Cells were stained for DX5 and CD3
prior to quantifying by flow cytometry by comparison to a known
quantity of CountBright Absolute counting beads (Molecular
Probes, Invitrogen, USA) on a Cyan ADP LX 9 color flow
cytometer (DAKO, UK). Chemotactic index calculated as cell
number migrated to chemoattractant/cell number to media/PBS
alone.
Detection of CCL3 RNA
Total RNA was extracted from snap-frozen lung using RNA-
Stat-60
TM according to manufacturer’s instructions (Tel-Test, TX).
cDNA, from 2 mg RNA, was generated with random hexamers
using Omniscript RT (Qiagen). TaqMan PCR was performed
using an ABI 7000 (Applied Biosystems) and analyzed using SDS
v1.2.3. The following primers and probe were used: CCL3,
Forward primer: CATCGTTGACTATTTTGAAACCAG, Re-
verse primer: GCCGGTTTCTCTTAGTCAGGAA and probe
59-FAM-AGCCTTTGCTCCCAGCCAGGTGTC-TAMRA-39.
Copy numbers were determined against standard curves.
RSV Plaque Assay
RSV titer from lungs was assessed using plaque assay as
described previously [22].
Detection of Cytokine Secretion by ELISPOT
ELISPOT were performed as described before [22]. Multi-
screen 96-well immobilon-P filtration plates were coated with
purified anti-IFNc (4 mg/ml; R&D) overnight at 4uC. Lung cells
were stimulated with 2 PFU/cell RSV or HEp-2 cell lysate for 2
days at 37uC. Detection was performed using biotinylated anti-
IFNc, followed by streptavidin-alkaline phosphatase. Bound
antibody was visualized by incubating plates with substrate
BCIP/NBT (Sigma). After drying, spots were enumerated on an
inverted microscope.
Statistical Analysis
Statistical significance between experimental groups was
determined by ANOVA and post test or Student’s t test using
GraphPad Prism software.
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